NNC-45-0095

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameNNC-45-0095

Drug Alias NameNNC-45-0095

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEstrogen receptors agonists

TargetsEstrogen receptors

Therapy Area/IndicationsOsteoporosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNovo Nordisk A/S

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNovo Nordisk A/S

Active IndicationsN/A

Inactive IndicationsOsteoporosis

ATC CodeN/A